Three Health Care Stocks That Could Revitalize Your Portfolio This November
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 04 2025
0mins
Source: Benzinga
Oversold Stocks Opportunity: The health care sector has several oversold stocks, presenting potential buying opportunities for undervalued companies, particularly those with a Relative Strength Index (RSI) below 30.
Alvotech SA Update: Alvotech's stock dropped 41% over the past month following an FDA Complete Response Letter regarding its AVT05 biosimilar application, with an RSI of 18.8 and a closing price of $5.03.
Acadia Healthcare Performance: Acadia Healthcare's stock fell 19% in the last month, with an RSI of 27.9, and it closed at $21.31 ahead of its third-quarter results announcement.
Akebia Therapeutics Decline: Akebia Therapeutics experienced a 33% drop in stock price over five days, with an RSI of 29.4, closing at $2.12 after reporting inducement grants.
Discover Tomorrow's Bullish Stocks Today
Receive free daily stock recommendations and professional analysis to optimize your portfolio's potential.
Sign up now to unlock expert insights and stay one step ahead of the market trends.
Analyst Views on ACHC
Wall Street analysts forecast ACHC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ACHC is 19.55 USD with a low forecast of 13.00 USD and a high forecast of 27.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
11 Analyst Rating
6 Buy
4 Hold
1 Sell
Moderate Buy
Current: 13.440
Low
13.00
Averages
19.55
High
27.00
Current: 13.440
Low
13.00
Averages
19.55
High
27.00
About ACHC
Acadia Healthcare Company, Inc. is a provider of behavioral healthcare services across the United States. It provides behavioral healthcare services to its patients in a variety of settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers and outpatient clinics. Its acute inpatient psychiatric facilities provide a high level of care in order to stabilize patients that are either a threat to themselves or to others. Its specialty treatment facilities include residential recovery facilities and eating disorder facilities. Its comprehensive treatment centers specialize in providing medication-assisted treatment in an outpatient setting. Its residential treatment centers treat patients with behavioral disorders in a non-hospital setting. The facilities balance therapy activities with social, academic and other activities. It operates a network of 262 behavioral healthcare facilities with over 11,850 beds in 39 states and Puerto Rico.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Trump Threatens Tariffs, Market Drops 1.5% Amid Risk-Off Sentiment
- Market Reaction: The S&P 500 fell 1.5% to 6,840 points due to Trump's aggressive trade stance towards Europe, marking its worst session since late November, primarily dragged down by consumer discretionary and technology stocks.
- Tariff Threats: Trump threatened to impose a 10% tariff on several European countries starting February 1 if negotiations over Greenland control fail, with potential increases to 25% by June, which could impact up to 25% of U.S. exports to Europe, leading to cautious market reactions.
- Fixed Income Volatility: Long-dated Treasury yields climbed to their highest levels since late September, with the 30-year yield rising 6 basis points to 4.90%, reflecting a risk-off sentiment among investors.
- Precious Metals Surge: Safe-haven demand pushed gold prices up 1.9% to $4,760 per ounce and silver nearly 5% to $94.50 per ounce, indicating market concerns over economic uncertainty.
Continue Reading
Acadia Healthcare Appoints Debra K. Osteen as CEO, Stock Surges 21.49%
- Executive Transition: Debra K. Osteen has been appointed as CEO of Acadia effective immediately, succeeding Chris Hunter who stepped down from the Board, indicating a significant leadership change that may influence future strategic directions.
- Financial Guidance Reaffirmed: Acadia reiterated its revenue guidance for 2025 at $3.28 billion to $3.30 billion and adjusted EPS guidance of $1.94 to $2.04, demonstrating the company's confidence in its future performance, which may attract more investor interest.
- Positive Market Reaction: Following the executive transition announcement, Acadia's stock surged 21.49% to $14.20, reflecting market optimism regarding the new leadership and potentially enhancing the company's competitive position.
- Historical Performance Review: For the fiscal year 2024, Acadia reported total revenue of $3.15 billion, indicating stable growth over the past year, and with the new CEO at the helm, further business expansion is anticipated.
Continue Reading